Answers are grounded in this paper and cite their sources.
Tumor-derived transforming growth factor β1 (TGFβ1) generally abrogates the immunogenicity of dendritic cells (DCs) fused to whole cancer cells. We have recently revealed that ethanol-treated neoplastic cells fused to DCs exposed to 2 Toll-like receptor agonists efficiently induce cytotoxic T lymphocytes via TGFβ1 blockade and the production of interleukin-12.
No takes yet. Share an insight, caveat, or question.
Koido et al. (2013) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: